Surgery for Advanced Lung Cancer by Tomita Masao et al.
Arta Med. Nagasaki 36: 166-169
Surgery for Advanced Lung Cancer
Masao TOMITA, Hiroyoshi AYABE, Katsunobu KAWAHARA 
   Yutaka TAGAWA, Shinsuke HARA, Hiroharu TSUJI 
                and Tadayuki OKA
  The First Department of Surgery, 
Nagasaki University School of Medicine
Received for publication, May 31, 1991
ABSTRACT : Twenty-one patients with advanced lung cancer who underwent 
surgery were clinically reviewed on the basis of clinical experience at the First Department 
of Surgery, Nagasaki University School of Medicine. 
   The surgical outcome was related to the intensity of surgical insult, which implied 
the grade of cancer progression. However, aggressive surgery is effective in a palliation 
of patient's surffering regardless its time duration. 
   It is emphasized that surgeons should be aware of establishment of safety operation 
and of elimination of the risk of cancer spreading during surgical manipulation to improve 
surgical outcome for advanced lung cancer.
       INTRODUCTION 
 The prognosis of extended resection for ad-
vanced lung cancer is now still poor, and it takes 
it into considerations that surgical treatment is 
dubious value. 
 However, according to advances in postopera-
tive cares and surgical techniques of surgical 
treatment, surgical outcome has become im-
proved gradually even in patients with the 
disease stage IV. 
 In fact, surgical treatment is at times indicat-
ed for patients with advanced lung cancer on 
account of palliation from patient's suffering 
even though it were limited to the short-term 
effect. 
 The purpose of this study is to certify validi-
ty of an extended surgery for advanced lung 
cancers with involvement of the mediastinum 
(T4).
          PATIENTS 
 During the time from Janurary 1967 to 
December 190, 21 patients with lung cancer of 
T4 were surgically treated at the First Depart-
ment of Surgery, Nagasaki University School of 
Medicine. 
 These patients accounted for 2.8% of a total 
of patients, who were operated upon at the same 
time period. 
 The ages ranged from 47 to 74 years old with 
an average of 61.4. The sex distribution was 
20: 1 of men to women. 
 Histologic types were distributed in squa-
mous cell carcinoma of 13 patients (59.1%), in 
adenocarcinoma of six (27.3%) and lange cell 
carcioma of two (9.0%), respectively. 
 According to N factor, T4No included two 
patients (9.0%) and T4N2 19 patients (86.4%). As 
for surgical curability, relative non-curative 
operation was performed in 20 patients although 
absolute non-curative operation was in one. 
 Surgical outcome was shown in Table 1. The
Table 1. Surgical outcome following surgery for 
        T4 lung patients 
  Survival time Cases 
Death cases 
  Operative death 3(14.2%) 
    ^-6 months 7(33 .3%) 
     ^-1 year 3 
     ^-2 years 4
     ^-3 years 1 
  over 3 years 0 
Alived cases 
      7 months pleuritis carcinomatosa 
      8 months thoracic wall resection 
                      and SVC replacement
     2 years and tracheal bifurcation 
        4 months reconstruction 
                      and SVC replacement
Table 2. Surgical procedures for involved organs 
1) SVC 
     circumferential resection 5 
     partal resection 3
2) tracheal birfurcation 
     resection and reconstruction 2 
     sleeve pneumonectomy 3
3) Aorta 
     circumferential resection 2 
     partial resection 2
     using extracorporeal circulation 1 
4) pleuritis carcinomatosa 
     panpleuropneumonectomy 1 
5) Left atrium 
     partial resection 3 
6) Esophagus 
     subtotal resection 1 
     segmental resection 1
     resection of 
         adventitiomucular layer 2
operative deaths occurred in three patients 
(14.2%) and 33.3% (seven patients) died within 
six months following surgery. On the contrary, 
survivors over one year were eight patients 
(38.0%). In addition, three patients were still 
alived well from seven months to two years and 
four months. One of them was expected to be 
the longest survivor more than three years fol-
lowing surgery. 
 Surgical procedures were indicated in Table 
2. As a rule, complete resection was attempt-
        Table 3. The causes of deaths 
causes patients (9% 
operative death 3(14.2%) 
   bronchopulmonary fisutla 
   respiratory failure+renal failure 
death less than 6 months after surgery 7(33.3%) 
   bronchial fistula with aortic rupture 
   cerebral infarct+renal failure 
   recurrence local 
           E distant 
death more than 6 months after surgery 11 (52.4%) 
    recurrence 
   other diseases
ed with node dissection as far as feasible. 
Extracorporeal circulation also was used for a 
resection of left atrium and aortic wall. How-
ever, the prognosis of patients with extracor-
poreal circulation was extremely poor, because 
of partly advanced cancer, party side effects of 
extracorporeal circulation of inappropriate myo-
cardial protection, prevention of air embolism 
and hemolysis. 
 The causes of deaths following surgery were 
summerized in Table 3. The operative deaths 
were encounted in three (1.4.2 %). These causes 
were bronchopulmonary fistula in two and 
respiratory failure, followed by renal failure in 
one respectively. The former could be avoided 
by meticulous and careful management during 
surgery. The later was based on postperfusion 
lung syndrome by extracorporeal circulation. 
The causes of death less than six months after 
surgery were bronchial fistula, followed by aortic 
rupture in one, cerebral infarction in one and 
recurrence of carcinomas in five respectively. 
After the repair of the wall of the aorta, 
bronchial fistula occurring at bronchial stump 
should be avoided. 
 In spite of an aggressive surgery for advanced 
cancer, local recurrence was noted within six 
months after surgery in some cases. It is a 
reflection of incomplete resection with the overt 
cancer residue and a presence of rnicrome-
tastasis.
         DISCUSSION 
 In advanced lung cancer, the indication of 
surgical treatment should be limited because of
poor prognosis. The commonly held view is that 
preoperative evaluation for the extent of cancer 
infiltration and the spreading of metastasis was 
not necessarily accurate. It is frequent that 
postoperatively histologic examination certify 
the extent of cancer extension including a 
presence of intrapulmonary metastasis. And/or 
the involvement of the adjacent organs. It is 
reported that the incidence of intrapulmonary 
metastasis by postoporatively histologic ex-
amination is 6.5%. 
 Kinoshita" reported that intrapulmonary 
metastatic lesions existed in another pulmonary 
lobes in one third of patients. 
 The more the sizes of intrapulmonary me-
tastases and the number of node involvement 
increased, the more the number of intrapul-
monary metastases proportionally increased". 
 It is accepted that the prognosis of patients 
with extensive node metastasis is extremely 
poor. It is believed that even aggressive surgical 
approaches fail to ensure oncologic radicality 
for advanced cancer patients. It is well known 
that cancer extension originates from the angle 
of the jugular vein and extends to the lung and 
the distant organ via pulmonary circulation'). 
 In addition, advances in surgery have made 
it possible to undergo combined resections 
with the neighbouring organs by using cardio-
pulmonary bypass'-'). 
 The use of cardiopulmonary bypss benefit 
surgeous from ensurement of an operative field 
without blood, capable for opening the trachea 
and bronchi under unventilated lungs and able 
to minimize the chance of blood-bore metasta-
sis. 
 According to some investigators7-9) , it is 
certified that a resection of 30% to 40% of the 
left atrium is feasible as the resected extent. 
Needless to say, this procedure is mondatory 
for surgical treatment of patients with advanced 
lung cancer, in particular, directly involving the 
wall of the left atrium. 
 In this series, the prognosis for patients with 
advanced lung cancer is not satisfactory. On 
the other hand, it was confirmed that combined 
resection with involving organs is clinically 
feasible to achieve a high quality of operative 
radicality. 
 It is well recognized that tumor cells that
infiltrate into the lumen of the great vessel could 
induce the deposition of fibrin as a framework 
to support continued cancer growth. Sometimes 
the tumor thrombosis may extend along the vein 
into the heart chamber, which is sufficient to 
impair blood flow and cardiac action"'. The 
patients with cancer infiltration to the left atrial 
wall should be warned of left ventricular in-
flow obstruction or lethal thrombosis in 
systemic arteries", 12) It is believed that aggres-
sive surgical management using a cardiopul-
monary bypass is effective in prolonging the 
survival time despite still unsatisfactory out-
come. The reasons for poor prognosis are 
that there is a possibility of intraoperative 
dissemination during mamipulation. The 
problem of how prevent the dissemination 
before and during cardiopulmonary bypass 
should be solved and obtain a satisfactory result 
in the future.
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